Cargando…

Role of a Modified Urothelium Immune Prognostic Index in Patients With Metastatic Urothelial Carcinoma Treated With Anti–PD-1/PD-L1–Based Therapy

Introduction: The use of antibodies against programmed death receptor-1 (PD-1) and its ligand (PD-L1) has improved survival in metastatic urothelial carcinoma (mUC) patients. However, reliable and convenient biomarkers of early responses and outcomes are still lacking. Materials and Methods: We retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Haifeng, An, Xin, Huang, Riqing, Li, Lu, Chu, Chengbiao, Yang, Wei, Qin, Zike, Liu, Zhuowei, Zhou, Fangjian, Xue, Cong, Shi, Yanxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387676/ https://www.ncbi.nlm.nih.gov/pubmed/34458319 http://dx.doi.org/10.3389/fmolb.2021.621883

Ejemplares similares

Investigating the Role of the N-Terminal Loop of PD-1 in Binding Process Between PD-1 and Nivolumab via Molecular Dynamics Simulation
por: Liu, Wenping, et al.
Publicado: (2020)

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue
por: Sommer, Ulrich, et al.
Publicado: (2022)

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer
por: Nie, Xiaoqun, et al.
Publicado: (2021)

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination
por: Wang, Zhiguo, et al.
Publicado: (2022)

Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival
por: Kalinin, R. S., et al.
Publicado: (2021)

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
por: You, Yang, et al.
Publicado: (2021)

Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy
por: Zhou, Chenfei, et al.
Publicado: (2023)

Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
por: Liang, Yimin, et al.
Publicado: (2022)

HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
por: Chen, Meiting, et al.
Publicado: (2023)

Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8(+) T Cells in Chinese Advanced Non–Small-Cell Lung Cancer Patients Treated With the Anti–PD-L1 Antibody
por: Sheng, Jin, et al.
Publicado: (2021)

PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma
por: Chen, Yuangui, et al.
Publicado: (2021)

Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset
por: Dai, Dongjun, et al.
Publicado: (2021)

PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
por: Dowell, Alexander C., et al.
Publicado: (2021)

Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer
por: Xu, Chaojie, et al.
Publicado: (2022)

SERS Based Lateral Flow Assay for Rapid and Ultrasensitive Quantification of Dual Laryngeal Squamous Cell Carcinoma-Related miRNA Biomarkers in Human Serum Using Pd-Au Core-Shell Nanorods and Catalytic Hairpin Assembly
por: Li, Guang, et al.
Publicado: (2022)

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2022)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study
por: Huang, Riqing, et al.
Publicado: (2023)

Exosome-Transmitted miR-128 Targets CCL18 to Inhibit the Proliferation and Metastasis of Urothelial Carcinoma
por: Shang, Donghao, et al.
Publicado: (2022)

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
por: Kumar, Utpal, et al.
Publicado: (2021)

Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice
por: Smeda, Marta, et al.
Publicado: (2022)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

B-Cell Receptor-Associated Protein 31 Negatively Regulates the Expression of Monoamine Oxidase A Via R1
por: Jia, Cong-cong, et al.
Publicado: (2020)

Erratum: Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice
Publicado: (2023)

Six-Month Outcomes of Post-ARDS Pulmonary Fibrosis in Patients With H1N1 Pneumonia
por: Gao, Jing, et al.
Publicado: (2021)

Molecular Mechanism of Selective Binding of NMS-P118 to PARP-1 and PARP-2: A Computational Perspective
por: Wang, Ran, et al.
Publicado: (2020)

PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis
por: Tan, Wei Phin, et al.
Publicado: (2019)

Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy
por: Yang, Xiuyan, et al.
Publicado: (2021)

RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
por: Liu, Shan, et al.
Publicado: (2021)

Potential antagonistic relationship of fgf9 and rspo1 genes in WNT4 pathway to regulate the sex differentiation in Chinese giant salamander (Andrias davidianus)
por: Zhang, Jiankang, et al.
Publicado: (2022)

A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1
por: Fagbadebo, Funmilayo O., et al.
Publicado: (2022)

Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
por: Liu, Shan, et al.
Publicado: (2022)

The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
por: Huang, Suyang, et al.
Publicado: (2021)

Identification of a 3-Gene Prognostic Index for Papillary Thyroid Carcinoma
por: Zhong, Lin-Kun, et al.
Publicado: (2022)

The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors
por: Yang, Xuyang, et al.
Publicado: (2021)

Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Hit and Indexing Rate in Serial Crystallography: Incomparable Statistics
por: Nam, Ki Hyun
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9u7m4jfki3k53js99sei5o07la